Arcturus Therapeutics appoints SAB member
This article was originally published in Scrip
Executive Summary
Arcturus Therapeutics, a small interfering RNA and messenger RNA drug discovery and development company, has named Dr Michael R Hodges to its Scientific Advisory Board (SAB). Most recently Dr Hodges was vice-president of drug development and chief medical officer for Santaris – an RNA therapeutic platform company developing drugs for cancer, and infectious and metabolic diseases.